ArticleMedical science monitor : international medical journal of experimental and clinical research2019

(-)-Epigallocatechin-3-Gallate Protects Against Lithium-Pilocarpine-Induced Epilepsy by Inhibiting the Toll-Like Receptor 4 (TLR4)/Nuclear Factor-κB (NF-κB) Signaling Pathway.

Zhenzhen Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.